Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.607NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.163NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.337NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.158NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.602NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.289NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.7.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.507NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.178NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.273NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.211NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.474NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.297NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AH.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.280NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.597NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.72NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.43NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.85NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.66 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.72 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.133 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.7 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.33.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.493NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.351.2 (Beta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.640.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.352NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.251NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCJNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FT.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EK.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.66NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GS.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.21.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EE.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used